Nalaganje...

Coronary heart disease mortality in severe vs. non-severe familial hypercholesterolaemia in the Simon Broome Register

BACKGROUND AND AIMS: The International Atherosclerosis Society (IAS) has proposed that patients with “severe” FH (SFH) would warrant early and more aggressive cholesterol-lowering treatment such as with PCSK9 inhibitors. SFH is diagnosed if LDL-cholesterol (LDLC) > 10 mmol/L, or LDLC >8.0 mmol...

Popoln opis

Shranjeno v:

Bibliografske podrobnosti
izdano v:	Atherosclerosis
Main Authors:	Humphries, Steve E., Cooper, Jackie A., Capps, Nigel, Durrington, Paul N., Jones, Ben, McDowell, Ian F.W., Soran, Handrean, Neil, Andrew H.W.
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2019
Teme:	Article
Online dostop:	https://ncbi.nlm.nih.gov/pmc/articles/PMC6403443/ https://ncbi.nlm.nih.gov/pubmed/30458964 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.atherosclerosis.2018.11.014
Oznake:	Označite Brez oznak, prvi označite!

Coronary heart disease mortality in severe vs. non-severe familial hypercholesterolaemia in the Simon Broome Register

Podobne knjige/članki